Tech has been a big driver of market resilience this year, with AI specifically boosting earnings for all kinds of companies. That said, technology isn’t just moving forward in software. Technology also includes biotech, with a potentially similar event to ChatGPT’s explosive arrival in the cards. The U.S. government appears poised to approve a gene [...] The post Play US Gene Treatment Approval in SBIO appeared first on ETF Trends .